AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor EventBusiness Wire • 03/19/25
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual ConferenceBusiness Wire • 03/10/25
ANGO Stock Looks Promising on New Ischemia Study for Auryon SystemZacks Investment Research • 01/31/25
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb IschemiaBusiness Wire • 01/30/25
AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The SharesSeeking Alpha • 01/16/25
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin DeclinesZacks Investment Research • 01/09/25
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ SystemBusiness Wire • 01/06/25
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor EventBusiness Wire • 12/19/24
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnifeZacks Investment Research • 12/10/24
Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?Zacks Investment Research • 12/10/24
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue AblationBusiness Wire • 12/09/24
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to TradeZacks Investment Research • 11/01/24
ANGO Stock Rises Following the Receipt of CPT Category I Code for IREZacks Investment Research • 10/23/24
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® SystemBusiness Wire • 10/23/24
AngioDynamics Announces American Medical Association's CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and LiverBusiness Wire • 10/21/24